Association Between Inflammatory Skin Disease and Cardiovascular and Cerebrovascular Co-Morbidities in US Adults: Analysis of Nationwide Inpatient Sample Data

[1]  R. Pujol,et al.  Use of biological treatments in patients with hidradenitis suppurativa. , 2017, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[2]  J. Silverberg,et al.  Inpatient Financial Burden of Atopic Dermatitis in the United States. , 2017, The Journal of investigative dermatology.

[3]  J. Silverberg,et al.  Validation of International Classification of Disease Ninth Revision codes for atopic dermatitis , 2017, Allergy.

[4]  N. Desai,et al.  High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics , 2017, The British journal of dermatology.

[5]  S. Langan,et al.  Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A. , 2017, The British journal of dermatology.

[6]  J. Silverberg,et al.  Association of atopic dermatitis with smoking: A systematic review and meta-analysis. , 2016, Journal of the American Academy of Dermatology.

[7]  A. Kouris,et al.  Quality of life, depression, anxiety and loneliness in patients with bullous pemphigoid. A case control study* , 2016, Anais brasileiros de dermatologia.

[8]  K. Tasanen,et al.  Risk of Death in Bullous Pemphigoid: A Retrospective Database Study in Finland. , 2016, Acta dermato-venereologica.

[9]  J. Silverberg,et al.  Atopic Dermatitis Is Associated with Less Physical Activity in US Adults. , 2016, The Journal of investigative dermatology.

[10]  J. Silverberg,et al.  The inpatient burden of psoriasis in the United States. , 2016, Journal of the American Academy of Dermatology.

[11]  J. Silverberg,et al.  Associations of Physical Activity and Sedentary Behavior with Atopic Disease in United States Children. , 2016, The Journal of pediatrics.

[12]  J. Silverberg,et al.  Costs of Care for Hospitalization for Pemphigus in the United States. , 2016, JAMA dermatology.

[13]  H. Asayesh,et al.  Risk factors in patients with oral pemphigus vulgaris: a case-control study. , 2016, General dentistry.

[14]  J. Silverberg,et al.  Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid , 2016, The British journal of dermatology.

[15]  J. Silverberg,et al.  A systematic review of vigorous physical activity in eczema , 2016, The British journal of dermatology.

[16]  M. Augustin,et al.  Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit , 2016, American Journal of Clinical Dermatology.

[17]  M. Gooderham,et al.  The psychosocial impact of hidradenitis suppurativa. , 2015, Journal of the American Academy of Dermatology.

[18]  S. Hadj-Rabia,et al.  Pemphigus and depression comorbidity: a case control study , 2015, European Journal of Dermatology.

[19]  J. Silverberg.  Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population‐based studies , 2015, Allergy.

[20]  M. Péntek,et al.  Health‐related quality of life and its determinants in pemphigus: a systematic review and meta‐analysis , 2015, The British journal of dermatology.

[21]  P. Wolkenstein,et al.  Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta‐analysis of observational studies , 2015, The British journal of dermatology.

[22]  J. Silverberg.  Health Care Utilization, Patient Costs, and Access to Care in US Adults With Eczema: A Population-Based Study. , 2015, JAMA dermatology.

[23]  J. Silverberg,et al.  Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. , 2015, Journal of the American Academy of Dermatology.

[24]  C. Vestergaard,et al.  A retrospective consecutive case-series study on the effect of systemic treatment, length of admission time, and co-morbidities in 98 bullous pemphigoid patients admitted to a tertiary centre. , 2015, Acta dermato-venereologica.

[25]  J. Silverberg,et al.  Eczema and cardiovascular risk factors in 2 US adult population studies. , 2015, The Journal of allergy and clinical immunology.

[26]  J. Silverberg,et al.  Central obesity and high blood pressure in pediatric patients with atopic dermatitis. , 2015, JAMA dermatology.

[27]  R. Malhotra,et al.  Association between psoriasis and leisure‐time physical activity: Findings from the National Health and Nutrition Examination Survey , 2015, The Journal of dermatology.

[28]  O. Savabi,et al.  Evaluation of interleukin-1α, interleukin-10, tumor necrosis factor-α and transforming growth factor-β in the serum of patients with pemphigus vulgaris. , 2014, The journal of contemporary dental practice.

[29]  A. Roselino,et al.  Prevalence of Metabolic Syndrome and its components in a Brazilian sample of pemphigus patients* , 2014, Anais brasileiros de dermatologia.

[30]  A. Kimball,et al.  The validity of the diagnostic code for hidradenitis suppurativa in an electronic database , 2014, The British journal of dermatology.

[31]  M. Tang,et al.  Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre , 2014, The British journal of dermatology.

[32]  Xiaojing Du,et al.  Overexpression of Interleukin-23 and Interleukin-17 in the Lesion of Pemphigus Vulgaris: A Preliminary Study , 2014, Mediators of inflammation.

[33]  A. Armstrong,et al.  Psoriasis and smoking: a systematic review and meta‐analysis , 2014, The British journal of dermatology.

[34]  T. Torres,et al.  Levels of Physical Activity in Patients with Severe Psoriasis: A Cross-Sectional Questionnaire Study , 2014, American Journal of Clinical Dermatology.

[35]  G. Jemec,et al.  Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. , 2013, Journal of the American Academy of Dermatology.

[36]  L. Herrinton,et al.  Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996–2009 , 2013, Pharmacoepidemiology and drug safety.

[37]  M. Suárez-Fariñas,et al.  Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. , 2013, The Journal of allergy and clinical immunology.

[38]  L. Arends,et al.  Markers of systemic inflammation in psoriasis: a systematic review and meta‐analysis , 2013, The British journal of dermatology.

[39]  O. Stasikowska-Kanicka,et al.  IL-17 Expression in Dermatitis Herpetiformis and Bullous Pemphigoid , 2013, Mediators of inflammation.

[40]  Laura K Ferris,et al.  Anti-cytokine therapy in the treatment of psoriasis. , 2013, Cytokine.

[41]  Patrick B. Wilson,et al.  Psoriasis and physical activity: a review , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[42]  J. Krueger,et al.  Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts. , 2011, The Journal of allergy and clinical immunology.

[43]  J. Laman,et al.  Elevated levels of tumour necrosis factor (TNF)‐α, interleukin (IL)‐1β and IL‐10 in hidradenitis suppurativa skin: a rationale for targeting TNF‐α and IL‐1β , 2011, The British journal of dermatology.

[44]  G. Vena,et al.  Psoriasis and cardiovascular disease , 2010, Dermatologic therapy.

[45]  Cynthia S Crowson,et al.  Potential misclassification of patients with psoriasis in electronic databases. , 2008, Journal of the American Academy of Dermatology.

[46]  James G. Krueger,et al.  Pathogenesis and therapy of psoriasis , 2007, Nature.

[47]  M. Chren,et al.  Association Between Poorer Quality of Life and Psychiatric Morbidity in Patients With Different Dermatological Conditions , 2004, Psychosomatic medicine.

[48]  G. Coman,et al.  ICAM-1, ELAM-1, TNF-alpha and IL-6 in serum and blister liquid of pemphigus vulgaris patients. , 1999, Roumanian archives of microbiology and immunology.

[49]  Schäfer,et al.  The influence of cultural and educational factors on the validity of symptom and diagnosis questions for atopic eczema , 1998, The British journal of dermatology.

[50]  Franco Ameglio,et al.  Bullous pemphigoid and pemphigus vulgaris: correlated behaviour of serum VEGF, sE-selectin and TNF-alpha levels. , 1997, Journal of biological regulators and homeostatic agents.

[51]  I. Hamzavi,et al.  Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa. , 2016, Dermatologic clinics.

[52]  古賀 千律子.  Possible pathogenic role of Th17 cells for atopic dermatitis , 2011 .

[53]  Hisashi Adachi,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[54]  M. Sprangers,et al.  Quality of life in patients with psoriasis: a systematic literature review. , 2004, The journal of investigative dermatology. Symposium proceedings.

[55]  ICD-9-CM coding and reporting official guidelines. American Hospital Association, American Medical Record Association, Health Care Financing Administration, National Center for Health Statistics. , 1990, Journal.